Lakshminarayanan Nandagopal

Lakshminarayanan Nandagopal
Assistant Professor

Associate Scientist, Experimental Therapeutics , O'Neal Comprehensive Cancer Center
Assistant Professor (P), Medicine - Hematology & Oncology , Department of Medicine 2018 -
Associate Scientist (C), O'Neal Comprehensive Cancer Center , School of Medicine 2020 -
Associate Scientist (C), Center for Clinical and Translational Science (CCTS) , General Clinical Research Center 2020 -

Selected Publications

Academic Article

Year	Title	Altmetric
2020	Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE) 2020
2020	Bladder cancer, version 3.2020 2020
2019	Investigational MET inhibitors to treat Renal cell carcinoma 2019
2019	Correction to: Immunotherapy Advances in Urothelial Carcinoma (Current Treatment Options in Oncology, (2018), 19, 12, (79), 10.1007/s11864-018-0598-x) 2019
2019	Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer 2019
2019	Featured updates to the NCCN guidelines 2019
2018	Correlation between Dt/V derived from ionic dialysance and blood-driven Kt/V of urea in African-American hemodialysis patients, based on body weight and ultrafiltration volume 2018
2018	Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma 2018
2017	Timing of androgen-deprivation therapy in prostate cancer 2017
2017	Treatment approaches of hard-to-treat non-Hodgkin lymphomas 2017
2016	Bronchoscopy can be done safely in patients with thrombocytopenia 2016
2016	Circulating biomarkers in bladder cancer 2016
2014	Ectopic ACTH and cisplatin toxicity-a diagnostic dilemma 2014
2013	A rare cause of dysphagia in a HIV patient - esophageal pseudodiverticulosis 2013
2013	Sterile peritonitis because of splenic infarction in a patient on peritoneal dialysis: An unusual presentation 2013

Research Overview

Dr. Nandagopal’s primary clinic interest is interested in genitourinary (GU) malignancies. His research interests are in developing clinical trials for GU malignancies, and development of correlative and prognostic biomarkers.

Principal Investigator On

Private Grant awarded by MERCK SHARP & DOHME CORP 2020 - 2025

Private Grant awarded by JOUNCE THERAPEUTICS, INC 2020 - 2025

Private Grant awarded by ASTRAZENECA PHARMACEUTICALS LP 2019 - 2024

Private Grant awarded by CALITHERA BIOSCIENCES INC 2019 - 2024

Private Grant awarded by I-MAB BIOPHARMA US LIMITED 2020 - 2023

Private Grant awarded by MEDIVATION, INC 2019 - 2021

UAB 1395 - Randomized Phase II Screening Trial of Enzalutamide/MDV-3100 and LHRH Analogue vs Combined Androgen Deprivation (LHRH Analogue + Bicalutamide) in Metastatic Hormone Sensitive Prostate Cancer awarded by KARMANOS CANCER CENTER 2019 - 2020

Investigator On

Private Grant awarded by ARCUS BIOSCIENCES INC 2020 - 2025

Private Grant awarded by ELI LILLY AND COMPANY 2019 - 2024

Private Grant awarded by ADURO BIOTECH, INC. 2019 - 2024

Private Grant awarded by CALITHERA BIOSCIENCES INC 2019 - 2024

Private Grant awarded by PUMA BIOTECHNOLOGY, INC. 2019 - 2024

Private Grant awarded by ASTRAZENECA PHARMACEUTICALS LP 2019 - 2024

Private Grant awarded by ASTRAZENECA AB 2018 - 2023

Private Grant awarded by CLOVIS ONCOLOGY 2017 - 2022

Alliance for Clinical Trials in Oncology Payment Agreement awarded by MAYO CLINIC 2017 - 2020

ECOG-ACRIN Purchase Service Agreement awarded by Eastern Cooperative Oncology Group 2014 - 2020

Education And Training

Bachelor of Medicine & Surgery (MBBS), Tamil Nadu Doctor M.G.R. Medical University 2007

Full Name

Lakshminarayanan Nandagopal